Shandong Polymer Biochemicals Stock Forum

Despite poor three-year revenue trends, the company's high P/S ratio could indicate a risk of share price decrease. Continuation of recent medium-term revenue trends could put shareholders and potential investors at significant risk.

Despite the slowing share price growth, the company's strong EPS growth indicates a potential undervaluation in the market. Given the strong momentum in its share price, it could be an opportunity for investors to examine the stock closely.